Quick Answer
ESCALON MEDICAL CORP reported R&D Expense of $753.1 thousand for fiscal year 2025.
ESCALON MEDICAL CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $753.1K | +9.4% |
| 2024 | $688.2K | -15.9% |
| 2023 | $818.8K | -17.4% |
| 2022 | $991.0K | +11.3% |
| 2021 | $890.5K | -20.7% |
| 2020 | $1.12M | +51.7% |
| 2019 | $739.8K | +47.9% |
| 2018 | $500.3K | -52.5% |
| 2017 | $1.05M | -27.4% |
| 2016 | $1.45M | +11.4% |
| 2015 | $1.30M | -0.4% |
| 2014 | $1.31M | +18.2% |
| 2013 | $1.11M | +10.0% |
| 2012 | $1.00M | -37.3% |
| 2011 | $1.60M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $131.2K | -15.9% | -39.3% |
| September 30, 2025 | $216.1K | +53.4% | +31.2% |
| March 31, 2025 | $164.8K | +5.7% | +5.7% |
| December 31, 2024 | $155.9K | +5.6% | +10.7% |
| September 30, 2024 | $140.9K | -33.4% | -9.6% |
| March 31, 2024 | $155.8K | -16.1% | +5.5% |
| December 31, 2023 | $147.7K | -22.8% | -30.2% |
| September 30, 2023 | $211.7K | -19.9% | +13.9% |
- ESCALON MEDICAL CORP showed an increase of +9.4% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2025 period, ESCALON MEDICAL CORP’s r&d expense has declined by 53.0% (from $1.60 million to $753.1 thousand).
- The most recent figure is from ESCALON MEDICAL CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: